跳至主要内容
临床试验/NCT03738670
NCT03738670终止不适用

Pain Evaluation After Treatment of Extra-spinal Bone Metastases With OsteoCOOL Radiofrequency (RF) Ablation System

University Hospital, Strasbourg, France2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2019年6月12日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
12
试验地点
2
主要终点
Percentage of responding patients reporting an improvement of at least 3 points on item 3 "the worst pain in the last 24 hours" of Brief Pain Inventory (BPI) questionnaire

研究概览

简要总结

To evaluate the worst pain of cancer patients with painful extra-spinal bone metastases 1 month after bipolar radiofrequency ablation (RFA) performed with the Osteocool system.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 1) Multi-metastatic cancer patients with at least one painful lytic bone metastasis
  • 2) Target lesion should correspond to a specific radiologic finding
  • 3) At least a moderate pain produce by target lesion (4 on a scale of 0 to 10 over the prior 24 hours with or without pain killers intake) assessed during selection evaluation
  • 4) Patients 18 years old
  • 5) Able to give written consent
  • 6) Life expectancy 1 months
  • 7) Patient affiliated to the National Health Insurance system

排除标准

  • Radiation therapy on the target tumor terminated < 3 weeks before treatment
  • Any contra-indication for the procedure as stated by the radiologist in terms of tumor size, proximity to neural/vascular structures making the procedure at unacceptable risk
  • Any contra-indication for the procedure as stated by the radiologist related to patient's condition (e.g. cardiac pacemakers) making the procedure at unacceptable risk
  • Impaired haemostasis
  • Concurrent participation in other experimental studies that could affect endpoints of this study
  • Contraindication to any form of sedation/anaesthesia
  • Signs of local/systemic infection identified before procedure, in accordance with standard care
  • Sclerotic metastases
  • Adults under guardianship
  • Patients under judicial protection
  • Pregnant or breastfeeding woman

结局指标

主要结局

Percentage of responding patients reporting an improvement of at least 3 points on item 3 "the worst pain in the last 24 hours" of Brief Pain Inventory (BPI) questionnaire

时间窗: 1 month

次要结局

  • Comparison of the mean scores of the items 3, 5, 9B and 8 of the BPI questionnaire between the baseline and 6-month follow-up(6 months)
  • Safety will be assessed according to SIR(11) / CTCAE classification(6 months)
  • Mean scores variation of the morphine milligram equivalents (MME) (based on patient consumption diary) between the baseline and 6-month follow-up.(6 months)
  • Percentage of responding patients defined by an improvement of at least 3 points on item 3 "the worst pain in the last 24 hours" of Brief Pain Inventory (BPI) questionnaire at 3 and 6 month follow-up.(6 months)

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验